Cerus Corp (CERS) stock
CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3022% below fair value
$1.94−0.18 (-8.49%)
Close on Nov 12, 2026Market cap $390.96MP/E –Yield –
Cerus ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cerus's ebitda for the twelve months ending Sep 30, 2026 was -$748.00K. For fiscal 2025 it was -$7.26M. The highest annual figure on record is -$7.26M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.26M | – |
| FY2024 | Dec 31, 2024 | -$12.37M | – |
| FY2023 | Dec 31, 2023 | -$27.45M | – |
| FY2022 | Dec 31, 2022 | -$31.10M | – |
| FY2021 | Dec 31, 2021 | -$45.79M | – |
| FY2020 | Dec 31, 2020 | -$55.22M | – |
| FY2019 | Dec 31, 2019 | -$63.82M | – |
| FY2018 | Dec 31, 2018 | -$53.54M | – |
| FY2017 | Dec 31, 2017 | -$55.72M | – |
| FY2016 | Dec 31, 2016 | -$59.63M | – |
| FY2015 | Dec 31, 2015 | -$59.38M | – |
| FY2014 | Dec 31, 2014 | -$43.09M | – |
| FY2013 | Dec 31, 2013 | -$27.55M | – |
| FY2012 | Dec 31, 2012 | -$16.56M | – |
| FY2011 | Dec 31, 2011 | -$15.00M | – |
| FY2010 | Dec 31, 2010 | -$15.11M | – |
| FY2009 | Dec 31, 2009 | -$22.97M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $804.00K | -50.3% |
| Q2 FY2026 | Jun 30, 2026 | -$1.40M | – |
| Q1 FY2026 | Mar 31, 2026 | $93.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$248.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $1.62M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.08M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.55M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.12M | -168.8% |
| Q3 FY2024 | Sep 30, 2024 | -$549.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.36M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.35M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.62M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.57M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.00M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.51M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.74M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.07M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.98M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.15M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.36M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.62M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.65M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.53M | – |
| Q3 FY2020 | Sep 30, 2020 | -$13.17M | – |
| Q2 FY2020 | Jun 30, 2020 | -$13.83M | – |
| Q1 FY2020 | Mar 31, 2020 | -$14.70M | – |
| Q4 FY2019 | Dec 31, 2019 | -$15.79M | – |
| Q3 FY2019 | Sep 30, 2019 | -$16.29M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.06M | – |
| Q1 FY2019 | Mar 31, 2019 | -$15.69M | – |
| Q4 FY2018 | Dec 31, 2018 | -$15.12M | – |
| Q3 FY2018 | Sep 30, 2018 | -$13.28M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.20M | – |
| Q1 FY2018 | Mar 31, 2018 | -$12.94M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.40M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.93M | – |
| Q2 FY2017 | Jun 30, 2017 | -$15.77M | – |
| Q1 FY2017 | Mar 31, 2017 | -$17.62M | – |
| Q4 FY2016 | Dec 31, 2016 | -$14.68M | – |
See a number that looks wrong?